Early Phase Clinical Trial Units (EPCTU)
Award Notice Posted
- Solicitation number
- 75N93022D00018
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93022D00018 Federal IDV award
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Allergy and Infectious Diseases awarded a contract to ICON Government and Public Health Solutions, Inc. to conduct Phase 0 through Phase II clinical trials domestically and internationally for small molecules, monoclonal antibodies, vaccines, and other immunomodulatory products against infectious diseases. The total value of the multiple award indefinite delivery contracts was estimated between $10,000 and $346,610,277. ICON Government and Public Health Solutions, Inc. was awarded $346,610,277 on January 14, 2022 to provide Early Phase Clinical Trial Units services.
Notice text
See Attachment for RFP-NIAID-NIH-AI-75N93020R00023.
Awarded contract 75N93022D00018 to ICON Government and Public Health Solutions, Inc. for 346610277.00 on 2022-01-14.
Files
| File | Type | Posted |
|---|---|---|
| RFP-NIAID-NIH-AI-75N93020R00023 Final.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| This notice | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Award Notice | |
| Early Phase Clinical Trial Units (EPCTU) | Solicitation | |
| Early Phase Clinical Trial Units (EPCTU) | Pre-Solicitation |
6 of 7 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity